A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes

NCT06263348 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

2000

Enrollment

INDUSTRY

Sponsor class

Conditions

Type2diabetes

Interventions

DRUG: Dorzagliatin tablets

Sponsor

Hua Medicine Limited

Collaborators

[object Object]